Commodore Capital LP
- SEC CIK
- 0001831942
- Latest filing
- Aug 14, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 15, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 32
- −3 vs. Q4 2022
- Portfolio value
- $656.8M
- −$6.71M (−1.0%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DBVTDBV Technologies S.A. | SPONSORED ADR | 92,687 | $156.6K | <0.1% | 00.0% | Unchanged | History |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 400,000 | $1.62M | 0.2% | −98,315−19.7% | Reduced | History |
| RZLTRezolute, Inc. | COM NEW | 898,267 | $1.72M | 0.3% | −311,733−25.8% | Reduced | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 312,553 | $2.46M | 0.4% | 00.0% | Unchanged | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 5,000,000 | $3.59M | 0.5% | +5,000,000 | New | History |
| THRDThird Harmonic Bio, Inc. | COM | 993,294 | $4.09M | 0.6% | 00.0% | Unchanged | History |
| ACRSAclaris Therapeutics, Inc. | COM | 635,000 | $5.14M | 0.8% | −1,245,286−66.2% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 200,000 | $7.50M | 1.1% | +26,519+15.3% | Added | History |
| ALLKAllakos Inc. | COM | 1,900,000 | $8.46M | 1.3% | +256,500+15.6% | Added | History |
| ENTAEnanta Pharmaceuticals Inc | COM | 217,253 | $8.79M | 1.3% | −6,241−2.8% | Reduced | History |
| Avidity Biosciences, Inc.05370A108 | COM | 590,705 | $9.07M | 1.4% | 00.0% | Unchanged | – |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 739,661 | $9.89M | 1.5% | 00.0% | Unchanged | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,325,000 | $10.2M | 1.6% | 00.0% | Unchanged | History |
| RXDXPrometheus Biosciences, Inc. | COM | 127,156 | $13.6M | 2.1% | 00.0% | Unchanged | History |
| CELCCelcuity Inc. | COM | 1,390,772 | $14.3M | 2.2% | +62,820+4.7% | Added | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 575,000 | $14.6M | 2.2% | +112,889+24.4% | Added | History |
| KURAKura Oncology, Inc. | COM | 1,204,958 | $14.7M | 2.2% | +105,551+9.6% | Added | History |
| CABACabaletta Bio, Inc. | COM | 1,835,000 | $15.2M | 2.3% | +824,641+81.6% | Added | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 2,025,000 | $17.7M | 2.7% | −3,713,500−64.7% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 495,823 | $17.8M | 2.7% | 00.0% | Unchanged | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 853,884 | $18.0M | 2.7% | +165,439+24.0% | Added | History |
| VERAVera Therapeutics, Inc. | CL A | 2,824,029 | $21.9M | 3.3% | +2,824,029 | New | History |
| IMVTImmunovant, Inc. | COM | 1,440,999 | $22.3M | 3.4% | +290,494+25.2% | Added | History |
| NUVLNuvalent, Inc. | COM | 1,075,000 | $28.0M | 4.3% | +161,379+17.7% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 790,000 | $30.2M | 4.6% | +252,924+47.1% | Added | History |
| ELVNEnliven Therapeutics, Inc. | COM | 1,731,365 | $37.9M | 5.8% | +1,731,365 | New | History |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 4,803,447 | $42.8M | 6.5% | +4,803,447 | New | History |
| Bellus Health Inc New07987C204 | COM NEW | 6,579,359 | $47.4M | 7.2% | +1,275,802+24.1% | Added | – |
| COGTCogent Biosciences, Inc. | COM | 4,772,421 | $51.5M | 7.8% | +452,481+10.5% | Added | History |
| MRUSMerus N.V. | COM | 2,950,000 | $54.3M | 8.3% | +217,433+8.0% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 2,189,659 | $55.7M | 8.5% | +169,493+8.4% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,845,000 | $66.0M | 10.1% | +185,889+11.2% | Added | History |
Sold out since Q4 2022 (7)
Positions held at the end of Q4 2022 that are gone from this filing.
| Security | Class | Shares in Q4 2022 | Value in Q4 2022 | % of portfolio in Q4 2022 | History |
|---|---|---|---|---|---|
| ACLXArcellx, Inc. | COMMON STOCK | 591,437 | $18.3M | 2.8% | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 598,385 | $13.3M | 2.0% | History |
| ELVNEnliven Therapeutics, Inc. | COM | 2,494,794 | $10.2M | 1.5% | History |
| ETNB89bio, Inc. | COM | 758,244 | $9.65M | 1.5% | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 1,935,609 | $6.58M | 1.0% | History |
| LRMRLarimar Therapeutics, Inc. | COM | 750,000 | $3.10M | 0.5% | History |
| IMUXImmunic, Inc. | COM | 1,800,000 | $2.52M | 0.4% | History |